Abbott India Ltd.
Snapshot View

20837.55 -440.70 ▼-2.1%

09 February 2023, 03:19:59 PM
Volume: 12,054

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.abbott.co.in
Market Cap 44,492.43 Cr.
Enterprise Value(EV) 43,415.28 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 414.96 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 50.46 Trailing Twelve Months Ending 2022-09
Industry PE 30.86 Trailing Twelve Months Ending 2022-09
Book Value / Share 1,277.45 Trailing Twelve Months Ending 2022-09
Price to Book Value 16.39 Calculated using Price: 20,938.30
Dividend Yield 1.31 Period Ending 2022-03
No. of Shares Subscribed 2.12 Cr. 21,249,302 Shares
FaceValue 10
Company Profile
The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.24%
1 Week
+1.57%
1 Month
-6.57%
3 Month
+8.21%
6 Month
+2.47%
1 Year
+24.76%
2 Year
+42.13%
5 Year
+271.14%
10 Year
+1403.13%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 27.66 26.54 23.93 21.54 26.35 24.66 27.09 27.89 29.95
Return on Capital Employed (%) 41.07 39.98 37.55 33.96 40.61 37.88 36.54 37.52 40.53
Return on Assets (%) 12.96 11.20 13.39 15.12 18.01 16.90 18.36 18.78 19.89

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 788 938 1,196 1,387 1,693 2,009 2,432 2,602 2,820 2,714
Non Curr. Liab. 443 432 29 35 41 62 210 190 184 166
Curr. Liab. 652 834 382 632 668 857 891 1,031 1,203 1,200
Minority Int.
Equity & Liab. 1,883 2,204 1,607 2,053 2,402 2,928 3,532 3,823 4,207 4,081
Non Curr. Assets 540 541 156 160 136 167 328 335 354 1,102
Curr. Assets 1,343 1,663 1,451 1,893 2,265 2,761 3,205 3,487 3,853 2,979
Misc. Exp. not W/O
Total Assets 1,883 2,204 1,607 2,053 2,402 2,928 3,532 3,823 4,207 4,081

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 2,276 2,289 2,615 2,903 3,299 3,679 4,093 4,310 4,919 5,163
Other Income 49 48 51 60 118 114 115 83 77 100
Total Income 2,325 2,338 2,666 2,963 3,417 3,793 4,208 4,393 4,997 5,263
Total Expenditure -2,009 -1,978 -2,251 -2,508 -2,775 -3,075 -3,337 -3,391 -3,832 -3,987
PBIDT 317 360 415 455 641 718 871 1,002 1,165 1,276
Interest 0 -1 -3 -2 -4 -2 -9 -18 -19 -18
Depreciation -22 -15 -14 -16 -16 -17 -60 -58 -66 -69
Taxation -96 -115 -143 -160 -220 -249 -210 -235 -281 -308
Exceptional Items
PAT 198 229 255 277 401 450 593 691 799 882
Adjusted EPS 93 108 120 130 189 212 279 325 376 415

Cash Flow View Details >>

Particulars 10 years 2012-12 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 101 155 215 249 307 153 499 626 727 948
Cash Fr. Inv. -59 -144 -187 -77 -155 -215 -257 -401 -72 -396
Cash Fr. Finan. -42 -42 -58 -80 -90 -102 -143 -217 -582 -637
Net Change 1 -31 -30 91 62 -165 99 8 73 -86
Cash & Cash Eqvt 109 79 49 140 202 38 137 145 218 133

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99
Public 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

No Corporate Announcement found.

Technical Scans View Details >>

Wed, 08 Feb 2023
Closing Above Previous High Closing Above Previous High
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 3 Months High Increase in 3 Months
High Increase in 1 Year High Increase in 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.65 -0.6%
Cipla Ltd. 83,886.47 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,485.00 -0.1%
Divi's Laboratories Ltd. 74,340.49 2,827.20 +1.0%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,386.10 -0.1%
Torrent Pharmaceuticals Ltd. 52,675.65 1,538.75 -1.2%
Zydus Lifesciences Ltd. 47,993.66 474.20 +0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.65 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,485.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,827.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,386.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,538.75 -1.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 474.20 +0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.65 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,485.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,827.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,386.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,538.75 -1.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 474.20 +0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.65 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,485.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,827.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,386.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,538.75 -1.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 474.20 +0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.65 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,485.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,827.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,386.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.75 -1.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.20 +0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.65 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,485.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,827.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,386.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,538.75 -1.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.20 +0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.65 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,485.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,827.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,386.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,538.75 -1.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 474.20 +0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.65 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,485.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,827.20 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,386.10 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,538.75 -1.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 474.20 +0.0%

FAQ's On Abbott India Ltd.

What is Abbott India share price?

Can I buy Abbott India shares now?

What is the Dividend Yield of Abbott India?

What is the Market Cap of Abbott India?

What are the key metrics to analyse Abbott India?

What is the 52 Week High and Low of Abbott India?

What is the trend of Abbott India share price?